<dhhead>BOARDS REPORT</dhhead>
Dear Members,
The Board of Directors hereby submits the report of the business and
operations of your Company ("the Company" or "J.G.Chemicals"), along
with the Audited Financial Statements, for the Financial Year ended March 31, 2025. The
consolidated performance of the Company and its Subsidiaries has been referred to wherever
required.
Results of our operations and state of a_airs
(in B Million, except per equity* share data)
Particulars |
Standalone |
Consolidated |
For the year ended March 31, |
For the year ended March 31, |
F.Y. 2024-25 |
FY 2023-24 |
F.Y. 2024-25 |
FY 2023-24 |
Revenue From Operation |
2,718.20 |
2,446.49 |
8,479.44 |
6,676.86 |
Other Income |
148.21 |
73.17 |
100.12 |
77.52 |
Total Income |
2,866.41 |
2,519.66 |
8,579.56 |
6,754.37 |
Total Expenses |
2,580.01 |
2,342.41 |
7,618.28 |
6,223.75 |
Profit/(Loss) Before
Finance Cost, Tax Expenses & Depreciation |
286.40 |
177.25 |
961.28 |
530.62 |
Finance Cost |
2.55 |
6.19 |
8.47 |
36.32 |
Depreciation |
13.85 |
9.01 |
53.81 |
45.26 |
Profit Before Tax |
270.00 |
162.06 |
899.00 |
449.04 |
Exceptional Item (Entry Tax for Earlier
Years) |
- |
18.02 |
- |
18.02 |
Profit after Exceptional Item and Before
Tax |
270.00 |
144.04 |
899.00 |
431.02 |
Less: Tax Expense |
69.81 |
36.17 |
231.40 |
109.94 |
Profit After Tax |
200.19 |
107.87 |
667.59 |
321.08 |
Total Other Comprehensive
Income / (Loss), Net of Tax |
22.66 |
47.19 |
23.46 |
47.19 |
Total comprehensive income for the year |
222.86 |
155.06 |
691.06 |
368.27 |
Profit Attributable to Owners of the
Company |
NA |
NA |
663.57 |
355.74 |
Non-Controlling Interest |
NA |
NA |
27.49 |
12.52 |
Earnings per Share (EPS)* |
|
|
|
|
Basic |
5.11 |
3.36 |
16.34 |
9.60 |
Diluted |
5.11 |
3.36 |
16.34 |
9.60 |
Notes:
The above figures are extracted from the Audited Standalone and
Consolidated Financial Statements of the Company as per the Indian Accounting Standards
(Ind AS).
Equity shares are at par value of B 10 per share.
FINANCIAL PERFORMANCE
Operating Results and Pro_ts
Consolidated revenue of the Company from operations (excluding from
discontinued operations) was B 8,479.44 million in FY25, which was 27.00% higher than the
consolidated revenue of B 6,676.86 million in FY24. The underlying EBITDA margin
(excluding from discontinued operations) was at 11.34% in FY25 as compared to 7.95% in
FY24. Underlying EBIT margin (excluding from discontinued operations) stood flat at 10.70%
in FY25 as compared to 7.27% in FY24. The profit before tax from continuing operation was
B 899.00 million in FY25 as against B 449.04 million in FY24. Profit for the year stood at
B 667.59 million in FY25 as compared to B 321.08 million in FY24.
Standalone revenue from operations was B 2,718.20 million in FY25
which was 11.11% higher than B 2,446.49 million in FY24. The profit before and after tax
for FY25 were B 270.00 million and B 200.19 million, respectively as compared to B 144.04
million and B 107.87 million, respectively for FY24. There was deferred tax charge of B
7.64 million in FY25 as compared to charge of B 6.43 million in FY24.
DIVIDEND
Declaration and Payment of Dividend
The Board of Directors (the Board) is pleased to recommend
declaration of a final dividend amounting to B 1.00/- per Ordinary/ Equity Share of face
value B 10/- each fully paid-up, i.e., (10.00%) for FY25. The Board has recommended the
dividend based on the parameters laid down in the Dividend Distribution Policy and
dividend will be paid out of the profits of the year. The said dividend, if approved by
the Members at the ensuing Annual General Meeting (the AGM) will be paid to
those Members whose name appears on the register of Members (including Beneficial Owners)
of the Company as at the end of Tuesday, August 5, 2025. The said dividend, would involve
cash outflow of B 39.19 Million, resulting in a payout of 19.57% of the standalone net
profit of the Company for FY25. Pursuant to the Finance Act, 2020, dividend income is
taxable in the hands of the Members, w.e.f. April 1, 2020 and the Company is required to
deduct tax at source from dividend paid to the Members at prescribed rates as per the
Income Tax Act, 1961.
Record Date
The Company has fixed Tuesday August 5, 2025 as the "Record
Date" for the purpose of determining the entitlement of Members to receive dividend
for FY25.
Dividend Distribution Policy
Pursuant to Regulation 43A of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI
Listing Regulations), the Board had formulated a Dividend Distribution Policy
(the Policy). The Policy is available on the Companys website URL at:
https://jgchem.com/wp-content/ uploads/2023/01/03.-DDP-16-06-22.pdf
TRANSFER TO RESERVES
The Board has decided to retain the entire amount of profit for FY25 in
the distributable retained earnings. An amount of B 200.19 Million was transferred to
retained earnings in FY25. The declared dividend amount will be distributed from the
Company's retained earnings.
CREDIT RATINGS
During the year under review, the Company had received its credit
ratings from CRISIL Ratings. M/s. CRISIL Limited have upgraded ratings as CRISIL A
(Stable) for Long term and CRISIL A1 for Short term based on all the Bank facilities taken
by the Company.
MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL
POSITION BETWEEN THE END OF THE FINANCIAL YEAR AND DATE OF THE REPORT
There have been no material changes and commitments, which affect the
financial position of the Company, that have occurred between the end of the financial
year to which the financial statements relate and the date of this report.
CONSOLIDATED FINANCIAL STATEMENT
The Consolidated Financial Statements of the Company and its
Subsidiaries for FY25 have been prepared in compliance with the applicable provisions of
the Act and as stipulated under Regulation 33 of SEBI Listing Regulations as well as in
accordance with the Indian Accounting Standards notified under the Companies (Indian
Accounting Standards) Rules, 2015. The Audited Consolidated Financial Statements together
with the Independent Auditors Report thereon form part of this Annual Report.
Pursuant to Section 129(3) of the Act, a statement containing the
salient features of the Financial Statement of the Subsidiary Companies is attached to the
Financial Statement in Form AOC-1.
Further, pursuant to the provisions of Section 136 of the Act, the
Company will make available the said financial statement of the Subsidiary Companies upon
a request by any Member of the Company or its Subsidiary Companies. These Financial
Statements of the Company and the Subsidiary Companies will also be kept open for
inspection by any member. The members can send an e-mail to cs@jgchem.com upto the date of
the AGM and the same would also be available on the Companys website URL: https://jgchem.com/financials/
SUBSIDIARY COMPANIES AND ASSOCIATE COMPANIES
The Company had one Subsidiary & no Associate Company during FY25
as disclosed in the Financial Statements. M/s. BDJ Oxides Private Limited is a material
subsidiary in accordance with Regulation 16 of the SEBI Listing Regulations.
There has been no material change in the nature of the business of the
subsidiary companies.
The policy for determining material subsidiaries of the Company is
available on the Companys website URL:
https://jgchem.com/wp-content/uploads/2023/01/05_MSP-01-20220525.pdf.
PROMOTERS GROUP SHAREHOLDING
As on March 31, 2025, the total shareholding of Promoter Group of your
Company stood at 70.99% (previous year 70.99%) in the Paid up Share Capital of the
Company. Members may refer to the Extract of Annual Return (MGT-9) for details of
Promoters Group shareholding.
In compliance with Regulation 31(2) of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements Regulations, 2015
("SEBI Listing Regulations, 2015"), the entire shareholding of Promoter(s) and
Promoter group is in dematerialized form.
CHANGES IN THE NATURE OF BUSINESS
The Company did not undergo any change in the nature of its business
during fiscal 2025.
RISK MANAGEMENT
The Company has established a structured Risk Management Framework to
identify, assess, and mitigate risks effectively. The Board has formed a Risk Management
Committee (RMC) to develop, implement, and monitor the Companys risk management
plan.
INTERNAL FINANCIAL CONTROL SYSTEM AND ADEQUACY
The Companys internal control systems are commensurate with the
nature of its business, the size and complexity of its operations and such internal
financial controls with reference to the Financial Statements are adequate.
Please refer to the paragraphs on Internal Control Systems and their
Adequacy in the Management Discussion & Analysis section for detailed analysis.
PARTICULARS OF EMPLOYEES AND REMUNERATION
Disclosure pertaining to remuneration and other details as required
under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 is annexed to the Report as Annexure-1.
In terms of proviso to Section 136(1) of the Act, the Report and
Accounts are being sent to the Shareholders, excluding the aforesaid Annexure. The said
Statement is also open for inspection. Any member interested in obtaining a copy of the
same may write to the Company Secretary at cs@jgchem.com.
CORPORATE SOCIAL RESPONSIBILITY
The brief outline of the Corporate Social Responsibility
(CSR) Policy of the Company and the initiatives undertaken by the Company on
CSR activities during the year in the format prescribed in the Companies (CSR
Policy) Rules, 2014 are set out in Annexure-2 of this Report. The CSR Policy
is available on Companys website at URL: at https://jgchem.com/wp-content/uploads/2023/01/15.CSR-01-20222025.pdf
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
EARNINGS AND OUTGO
The information on conservation of energy, technology absorption and
foreign exchange earnings and outgo stipulated under Section 134(3)(m) of the Act, read
along with Rule 8 of the Companies (Accounts) Rules, 2014, is annexed herewith as Annexure-3.
ANNUAL RETURN
Pursuant to Section 92(3) of the Act and Rule 12 of the Companies
(Management and Administration) Rules, 2014, the Annual Return for FY25 is uploaded on the
website of the Company and the same is available on https://jgchem.com/wp-content/
uploads/2025/07/MGT-7.pdf.
DIRECTORS AND KEY MANAGERIAL PERSONNEL (KMP)
Reappointment
Director liable to retire by rotation
Pursuant to the provisions of the Act, Mr. Suresh Jhunjhunwala,
Whole-time Director & Executive Chairman, whose term extends until May 15, 2030 and
who is liable to retire at the forthcoming Annual General Meeting, is eligible and has
offered himself for reappointment. Based on the performance evaluation and the
recommendation of the Nomination and Remuneration Committee, the Board recommends his
reappointment.
Retirements and resignations
During the year, there was no retirement or resignation of Directors or
KMP.
Independent Directors
In terms of Section 149 of the Act and the SEBI Listing Regulations, Mr
Ashok Bhandari, Mr Sukanta Nag and Mrs Savita Agarwal are the Independent Directors of the
Company as on the date of this Report.
The Company has received necessary declaration from each Independent
director that he / she meets the criteria of Independence laid down in Section 149(6),
Code for Independent directors of the Act and Regulation 16(1)(b) of the Listing
Regulations. The Independent Directors of the Company have undertaken requisite steps
towards the inclusion of their names in the data bank of Independent Directors maintained
with the Indian Institute of Corporate Affairs, in terms of Section 150 read with Rule 6
of the Companies (Appointment and Qualification of Directors) Rules, 2014.
Key Managerial Personnel
In terms of Section 203 of the Act, the Key Managerial Personnel
(KMPs) of the Company during FY25 are:
? Mr Anirudh Jhunjhunwala, CEO & Managing Director
? Mr Anuj Jhunjhunwala, Chief Financial Officer
? Ms. Swati Poddar, Company Secretary and Compliance Officer
During the year under review, there were no change in the KMPs of the
Company.
CORPORATE GOVERNANCE
Our corporate governance practices are a reflection of our value system
encompassing our culture, policies, and relationships with our stakeholders. Integrity and
transparency are key to our corporate governance practices to ensure that we gain and
retain the trust of our stakeholders at all times. Corporate governance is about
maximizing shareholder value legally, ethically and sustainably. At JG Chemicals, the
Board exercises its fiduciary responsibilities in the widest sense of the term. Our
disclosures seek to attain the best practices in national corporate governance. We also
endeavor to enhance long-term shareholder value in all our business decisions. Our
Corporate governance report for fiscal 2025 forms part of this Annual Report.
MANAGEMENTS DISCUSSION AND ANALYSIS
In terms of the provisions of Regulation 34 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 ("the Listing
Regulations") as amended from time to time, the Managements discussion and
analysis is set out in this Annual Report.
MEETINGS OF THE BOARD
The Board of Directors held 5 (Five) meetings during FY25. The meeting
details are provided in the Corporate governance report that forms part of this Annual
Report. The maximum interval between any two meetings did not exceed 120 days, as
prescribed by the Act.
COMMITTEES OF THE BOARD
The Committees of the Board focus on certain specific areas and make
informed decisions in line with the delegated authority.
The following Committees constituted by the Board function according to
their respective roles and defined scope:
? ?Audit Committee
? ?Nomination and Remuneration Committee ? ?Corporate Social
Responsibility Committee ? ?Stakeholders Relationship Committee ? ?Risk Management
Committee
Details of composition, terms of reference and number of meetings held
in FY25 for the aforementioned committees are given in the Report on Corporate Governance,
which forms a part of this Report. Further, during the year under review, all
recommendations made by the various committees have been considered and accepted by the
Board.
BOARD EVALUATION
The annual evaluation process of the Board of Directors, Individual
Directors and Committees was conducted in accordance with the provision of the Act and the
SEBI Listing Regulations. The Board evaluated its performance after seeking inputs from
all the Directors on the basis of criteria such as the Board composition and structure,
effectiveness of Board processes, information and functioning, etc. The performance of the
Committees was evaluated by the Board after seeking inputs from the committee members on
the basis of criteria such as the composition of Committees, effectiveness of Committee
meetings, etc. The above criteria are broadly based on the Guidance Note on Board
Evaluation issued by the SEBI.
The Board and the NRC reviewed the performance of Individual Directors
on the basis of criteria such as the contribution of the Individual Director to the Board
and Committee Meetings like preparedness on the issues to be discussed, meaningful and
constructive contribution and inputs in meetings, etc.
In a separate meeting of Independent directors, performance of
Non-Independent Directors and the Board as a whole was evaluated. Additionally, they also
evaluated the performance of Chairman of the Board, taking into account the views of
Executive and Non-Executive Directors in the aforesaid Meeting. The Board also assessed
the quality, quantity and timeliness of flow of information between the Company Management
and the Board that is necessary for the Board to effectively and reasonably perform their
duties. The above evaluations were then discussed in the Board Meeting and performance
evaluation of Independent directors was done by the entire Board, excluding the
Independent Director being evaluated.
FAMILIARISATION PROGRAMME FOR INDEPENDENT DIRECTORS
Please refer to the Paragraph on Familiarisation Programme in the
Corporate Governance Report for detailed analysis.
POLICYONDIRECTORSAPPOINTMENTANDREMUNERATION
The current policy is to have an appropriate mix of Executive,
Non-Executive and Independent Directors to maintain the Independence of the Board and
separate its functions of governance and management. As of March 31, 2025, the Board had
six members, consisting of an Three Executive Director and Three Independent Directors.
One of the Independent Directors of the Board are women. The details of Board and
Committee composition, tenure of directors, areas of expertise and other details are
available in the Board of Directors Profile section that forms part of this Annual
Reports.
The policy of the Company on directors appointment and
remuneration, including the criteria for determining qualifications, positive attributes,
independence of a director and other matters, as required under sub-section (3) of Section
178 of the Act, is available on our website, at https://jgchem.com/wp-content/
uploads/2023/01/06.-NREP-01-20220525.pdf
We affirm that the remuneration paid to the directors is as per the
terms laid out in the Nomination and Remuneration Policy of the Company.
VIGIL MECHANISM
The Company believes in the conduct of the affairs of its constituents
in a fair and transparent manner by adopting the highest standards of professionalism,
honesty, integrity and ethical behaviour. In line with the Code of Conduct
(CoC), any actual or potential violation, howsoever insignificant or perceived
as such, would be a matter of serious concern for the Company. The role of the employees
in pointing out such violations of the CoC cannot be undermined.
PursuanttoSection177(9)oftheAct,avigilmechanismwasestablished for
directors and employees to report to the management instances of unethical behaviour,
actual or suspected, fraud or violation of the Companys code of conduct or ethics
policy. The vigil mechanism provides adequate safeguards against victimization and
multiple channels for reporting concerns including an option for escalations, if any, to
the Chairperson of the Audit Committee of the Company.
The policy of vigil mechanism is available on the Companys
website at URL: https://jgchem.com/wp-content/uploads/2024/06/Whistle-Blower-Policy.pdf
AUDIT REPORTS & AUDITORS AUDIT REPORTS
The Auditors Report for fiscal 2025 does not contain any
qualification, reservation, or adverse remark. The report is enclosed with the financial
statements in this Annual Report.
The Secretarial Auditors Report for fiscal 2025 does not contain
any qualification, reservation, or adverse remark. The Secretarial Auditors Report
is enclosed as Annexure-4A to the Boards report, which forms part of this
Annual Report.
The Auditors Certificate confirming compliance with conditions of
corporate governance as stipulated under the Listing Regulations, for fiscal 2025 is
enclosed as Annexure-5 to the Boards report, which forms part of this Annual
Report.
AUDITORS
Statutory Auditor
M/s. S. Jaykishan, Chartered Accountants (Firm registration no:
309005E) was appointed as the statutory auditors of the Company, to hold office for a term
of four consecutive years from the conclusion of the 23rd AGM of the Company
held on September 29, 2023, till the conclusion of the 27th AGM to be held in
2027, as required under Section 139 of the Act read with the Companies (Audit and
Auditors) Rules, 2014.
Secretarial Auditor
Based on the recommendation of the Board in its meeting held on May 17,
2025, M/s. K. Arun & Co, Company Secretaries (Firm registration no: P1995WB046000), is
proposed to be appointed as secretarial auditors of the Company to hold office for a term
of five consecutive years commencing from financial year 2025-26 till financial year
2029-30 subject to the approval of shareholders as per the Listing Regulations read with
Section 204 of the Act and Rules thereunder.
Cost Records and Cost Audit
As per Section 148 of the Act, the Company is required to have the
audit of its cost records conducted by a Cost Accountant. The Board of Directors of the
Company has on the recommendation of the Audit Committee, approved the appointment of M/s.
Debobrata Banerjee and Associates, a firm of Cost Accountants in Practice (Registration No
003850) as the Cost Auditors of the Company to conduct cost audits for relevant products
prescribed under the Companies (Cost Records and Audit) Rules, 2014 for FY26. M/s.
Debobrata Banerjee and Associates have, under Section 139(1) of the Act and the Rules
framed thereunder furnished a certificate of their eligibility and consent for
appointment. The Board on recommendations of the Audit Committee have approved the
remuneration payable to the Cost Auditor, subject to ratification of their remuneration by
the Members at this AGM. The resolution approving the above proposal is being placed for
approval of the Members in the Notice for this AGM.
Reporting of frauds by auditors
During fiscal 2025, the statutory auditor and the secretarial auditor
have not reported any instance of fraud committed in the Company by its officers or
employees.
PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES
All contracts/ arrangements/ transactions entered by the Company during
the FY25 with related parties were valued on an arms length basis and in the
ordinary course of business and approved by the Audit Committee consisting of Independent
Directors. Certain transactions, which were repetitive in nature, were approved through
omnibus route.
As per the SEBI Listing Regulations, if any Related Party Transactions
(RPT) exceeds B 100 Million or 10% of the annual consolidated turnover as per
the last audited financial statement whichever is lower, would be considered as material
and would require Members approval. In this regard, during the year under review, the
Company has taken necessary Members approval. However, there were no material transactions
of the Company with any of its related parties during the year in terms of Section 134
read with Section 188 of the Companies Act, 2013. Therefore, the disclosure of the Related
Party Transactions as required under Section 134(3(h) of the Act in Form AOC-2 is not
applicable to the Company for FY25 and, hence, the same is not required to be provided.
The details of RPTs during FY25, including transaction with person or
entity belonging to the promoter/ promoter group which hold(s) 10% or more shareholding in
the Company are provided in the accompanying financial statements.
During FY25, the Non-Executive Directors of the Company had no
pecuniary relationship or transactions with the Company other than sitting fees,
commission and reimbursement of expenses, as applicable. Pursuant to SEBI Listing
Regulations, the Resolution for seeking approval of the Members on material related party
transactions is being placed at this AGM.
Pursuant to the requirements of the Act and the SEBI Listing
Regulations, the Company has formulated a policy on RPTs and is available on
Companys website URL at:
https://jgchem.com/wp-content/uploads/2024/02/JGCL-RPT-Policy-20.11.23.pdf .
PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
Loans, Guarantees and Investments covered under Section 186 of the
Companies Act,2013 ("the Act") form part of the notes to the financial
statements provided in this Annual Report.
FIXED DEPOSITS
We have not accepted any fixed deposits, including from the public,
and, as such, no amount of principal or interest was outstanding as of the Balance Sheet
date.
DIRECTORS RESPONSIBILITY STATEMENT
The financial statements are prepared in accordance with the Indian
Accounting Standards (Ind AS) under the historical cost convention on accrual basis except
for certain financial instruments, which are measured at fair values, and defined benefit
liability/(asset) which is recognized at the present value of defined benefit obligation
less fair value of plan assets, the provisions of the Act and guidelines issued by SEBI.
The Ind AS are prescribed under Section 133 of the Act, read with Rule 3 of the Companies
(Indian Accounting Standards) Rules, 2015 and relevant amendment rules issued thereafter.
Accounting policies have been consistently applied except where a newly issued accounting
standard is initially adopted or a revision to an existing accounting standard requires a
change in the accounting policy hitherto in use.
Pursuant to Section 134(5) of the Act, the Board, to the best of their
knowledge and based on the information and explanations received from the management of
your Company, confirm that:
A. in the preparation of the Annual Financial Statements, the
applicable accounting standards have been followed and there are no material departures.
B. they have selected such accounting policies and applied them
consistently and judgements and estimates that are reasonable and prudent so as to give a
true and fair view of the state of affairs of the Company at the end of the financial year
and of the profit of the Company for that period;
C. proper and sufficient care has been taken for the maintenance of
adequate accounting records in accordance with the provisions of the Act for safeguarding
the assets of the Company and for preventing and detecting fraud and other irregularities;
D. the annual financial statements have been prepared on a going
concern basis;
E. they have laid down internal financial controls to be followed by
the Company and that such internal financial controls are adequate and operating
effectively;
F. proper systems have been devised to ensure compliance with the
provisions of all applicable laws and that such systems are adequate and operating
effectively.
SECRETARIAL STANDARDS
The Company complies with all applicable secretarial standards issued
by the Institute of Company Secretaries of India.
LISTING ON STOCK EXCHANGES
The Companys shares are listed on BSE Limited and the National
Stock Exchange of India Limited.
SECRETARIAL AUDIT OF MATERIAL UNLISTED INDIAN SUBSIDIARY
As per regulation 24(A) of SEBI Listing Regulations, a listed company
is required to annex the secretarial audit report of its material unlisted subsidiary in
India to its Annual Report. BDJ Oxides Private Limited has been identified as Material
Unlisted Subsidiary of the Company in India for FY25 and accordingly the Company is
annexing the Secretarial Audit Report of BDJ Oxides Private Limited as Annexure 4B.
BOARD DIVERSITY
The Company recognizes and embraces the importance of a diverse Board
in its success. We believe that a truly diverse Board will leverage differences in
thought, perspective, regional and industry experience, cultural and geographical
background, age, ethnicity, race, gender, knowledge and skills, including expertise in
financial, diversity, global business, leadership, mergers and acquisitions, Board service
and governance, sales and marketing, risk management and other domains, which will ensure
that Company retains its competitive advantage. The Board Diversity Policy adopted by the
Board sets out its approach to diversity.
The policy is available on our website, at
https://jgchem.com/wp-content/uploads/2024/06/Board-Diversity-Policy.pdf.
Additional details on Board diversity are available in the Corporate
governance report that forms part of this Annual Report.
CODE FOR PREVENTION OF INSIDER TRADING
The Company has adopted a Code of Conduct ("Code") to
regulate, monitor and report trading in Companys shares by Companys designated
persons and their immediate relatives as per the requirements under the Securities and
Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The Code,
inter alia, lays down the procedures to be followed by designated persons while
trading/dealing in Companys shares and sharing Unpublished Price Sensitive
Information ("UPSI"). The Code covers Companys obligation to maintain a
digital database, mechanism for prevention of insider trading and handling of UPSI, and
the process to familiarise with the sensitivity of UPSI. Further, it also includes code
for practices and procedures for fair disclosure of unpublished price sensitive
information which has been made available on the Companys website and link for the
same may be accessed at https://jgchem.
com/wp-content/uploads/2023/01/19.-Code-I-TRD-01-20222025.pdf
The employees are required to undergo a mandatory training on this Code
to sensitise themselves and strengthen their awareness.
OTHER DISCLOSURES AND AFFIRMATIONS
The Directors state that no disclosure or reporting is required in
respect of the following matters as there were no transactions on these items during the
year under review:
? ?There were no significant material orders passed by the Regulators
or Courts or Tribunal, which would impact the going concern status of the Company and its
future operation.
? ?There were no proceedings initiated/ pending against the Company
under the Insolvency and Bankruptcy Code, 2016 before the National Company Law Tribunal or
any other court.
? ?During the financial year under review, there were no instances of
one-time settlement with any bank or financial institution.
ACKNOWLEDGEMENTS
The Directors wish to convey their appreciation to all of the
Companys employees for their contribution towards the Companys performance.
The Directors would also like to thank the members, employee unions, customers, dealers,
suppliers, bankers, governments and all other business associates for their continuous
support to the Company and their confidence in its management.
On behalf of the Board of Directors |
For J.G.Chemicals Limited |
Anirudh Jhunjhunwala |
Managing Director & CEO |
(DIN: 00234879) |
Suresh Jhunjhunwala |
Executive Chairman & WTD |
(DIN: 00234725) |
Date: June 27, 2025 |
Registered office: |
Adventz Infinity@5, |
Unit No. 1511, Street No. 18 |
BN Block, 15th Floor, Sector V, Salt Lake |
Kolkata -700091 |